The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: Correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial

European Heart Journal

Volumn 28, Issue 24, 2007, Pages 2985-2991

  Eskola, Markku J ^a   Holmvang, Lene ^b   Nikus, Kjell C ^a   Sclarovsky, Samuel ^c   Tilsted, Hans Henrik ^d   Huhtala, Heini ^e   Niemelä, Kari O ^a   Clemmensen, Peter ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b Mental Health Services CPH   (Denmark)

^c Procardia Medical Center   (Israel)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Electrocardiogram; Fibrinolysis; Myocardial infarction; Percutaneous coronary intervention; Prognosis; Risk stratification

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HAZARD ASSESSMENT; HEART DEATH; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; STROKE; T WAVE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 37149034938     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm428     Document Type: Article

References (30)

1. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
2. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992;86: 81-90.
3. Zeymer U, Schroder R, Neuhaus KL. Patency, perfusion and prognosis in acute myocardial infarct. Herz 1999;24:421-429.
4. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns WTask Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
5. Thune JJ, Hoefsten DE, Lindholm MG, Mortensen LS, Andersen HR, Nielsen TT, Kober L, Kelbaek H for the Danish Multicenter Randomized Study of Fibrinolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI)-2 Investigators. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation 2005;112:2017-2021.
6. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP Jr, Antman EM, Cannon CP, Gibson CM. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006;114:2019-2025.
7. Wilkins ML, Pryor AD, Maynard C, Wagner NB, Elias WJ, Litwin PE, Pahlm O, Selvester RH, Weaver WD, Wagner GS. An electrocardiographic acuteness score for quantifying the timing of a myocardial infarction to guide decisions regarding reperfusion therapy. Am J Cardiol 1995;75: 617-620.
8. Sclarovsky S. The evolving acute myocardial infarction. In: Sclarovsky S, ed. Electrocardiography of Acute Myocardial Ischaemic Syndromes. 1st ed. London: Martin Dunitz Ltd; 1999. p99-122.
9. Andersen HR, Nielsen TT, Vesterlund T, Grande P, Abildgaard U, Thayssen P, Pedersen F, Mortensen LS DANAMI-2 Investigators. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 2003;146:234-241.
10. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, Harrington RA, Krumholz HM, Simoons ML, Van De Werf FJ, Weintraub WS, Mitchell KR, Morrisson SL, Brindis RG, Anderson HV, Cannom DS, Chitwood WR, Cigarroa JE, Collins-Nakai RL, Ellis SG, Gibbons RJ, Grover FL, Heidenreich PA, Khandheria BK, Knoebel SB, Krumholz HL, Malenka DJ, Mark DB, Mckay CR, Passamani ER, Radford MJ, Riner RN, Schwartz JB, Shaw RE, Shemin RJ, Van Fossen DB, Verrier ED, Watkins MW, Phoubandith DR, Furnelli T. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114-2130.
11. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349:733-742.
12. Sejersten M, Ripa RS, Maynard C, Wagner GS, Andersen HR, Grande P, Mortensen LS, Clemmensen P. Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial). Am J Cardiol 2006;97:611-616.
13. Sejersten M, Birnbaum Y, Ripa RS, Maynard C, Wagner GS, Clemmensen P. Influences of electrocardiographic ischemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention (results from the DANAMI-2 trial). Heart 2006;92:1577-1582.
14. Corey KE, Maynard C, Pahlm O, Wilkins ML, Anderson ST, Cerqueira MD, Pryor AD, Raitt MH, Startt Selvester RH, Turner J, Weaver WD, Wagner GS. Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation. Am J Cardiol 1999;83:826-831.
15. Ripa RS, Persson E, Heden B, Maynard C, Christian TF, Hammill S, Pahlm O, Wagner GS. Comparison between human and automated electrocardiographic waveform measurements for calculating the Anderson-Wilkins acuteness score in patients with acute myocardial infarction. J Electrocardiol 2005;38:96-99.
16. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
17. Atak R, Ileri M, Senen K, Turhan H, Erbay AR, Basar N, Yetkin E, Demirkan D. Correlation between infarct-related coronary artery patency and predischarge electrocardiographic patterns in patients with first anterior myocardial infarction who received thrombolytic therapy. Heart Vessels 2004;19:63-67.
18. Agetsuma H, Hirai M, Hirayama H, Suzuki A, Takanaka C, Yabe S, Inagaki H, Takatsu F, Hayashi H, Saito H. Transient giant negative T wave in acute anterior myocardial infarction predicts R wave recovery and preservation of left ventricular function. Heart 1996;75:229-234.
19. Porter A, Mazur A, Solodky A, Birnbaum Y, Sulkes J, Imbar S, Strasberg B. Correlation of predischarge electrocardiographic patterns with left ventricular function in patients with anterior wall myocardial infarction. Cardiology 2000;93:163-167.
20. Doevendans PA, Gorgels AP, van der Zee R, Partouns J, Bar FW, Wellens HJ. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1995;75:1206-1210.
21. Sgarbossa EB, Meyer PM, Pinski SL, Pavlovic-Surjancev B, Barbagelata A, Goodman SG, Lum AS, Underwood DA, Gates KB, Califf RM, Topol EJ, Wagner GS. Negative Twaves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rate. Am Heart J 2000;140:385-394.
22. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
23. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, Branny M, St'asek J, Formanek P, 'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003;24:94-104.
24. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P, Comparison of Angioplasty Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851- 2856.
25. Brodie BR, Stuckey TD, Hansen C, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 2000;85:13-18.
26. Singh M, Reeder GS, Ohman EM, Mathew V, Hillegass WB, Anderson RD, Gallup DS, Garratt KN, Holmes DR Jr. Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An angiographic trials pool data experience. J Am Coll Cardiol 2001;38:624-630.
27. Cafri C, Svirsky R, Zelingher J, Slutky O, Kobal S, Weinstein JM, Ilia R, Gilutz H. Improved procedural results in coronary thrombosis are obtained with delayed percutaneous coronary interventions. J Invasive Cardiol 2004;16:69-71.
28. Blumenthal MR, Wang HH, Pang LM. Experimental coronary arterial occlusion and release. Effects on enzymes, electrocardiograms, myocardial contractility and reactive hyperemia. Am J Cardiol 1975;36:225-233.
29. Raitt MH, Maynard C, Wagner GS, Cerqueira MD, Selvester RH, Weaver WD. Appearance of abnormal Q waves early in the course of acute myocardial infarction: implications for efficacy of thrombolytic therapy. J Am Coll Cardiol 1995;25:1084-1088.
30. Wong CK, Gao W, Raffel OC, French JK, Stewart RA, White HD, HERO-2 Investigators. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2. Lancet 2006;367:2061-2067.